Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 171.86 K873.72 K2.87 M2.57 M985.31 K 7.3 M Research & development ————— — Operating income -171.86 K-873.72 K-2.87 M-2.57 M-985.31 K -7.3 M Non-Operating Income, Total 3.09 M3.06 M2.38 M3.74 M2.7 M 11.88 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 3.09 M3.06 M2.38 M3.74 M2.7 M 11.88 M Unusual income/expense ————— — Pretax income 2.91 M2.18 M-491.39 K1.17 M1.71 M 4.58 M Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 2.91 M2.18 M-491.39 K1.17 M1.71 M 4.58 M Discontinued operations ————— — Net income 2.91 M2.18 M-491.39 K1.17 M1.71 M 4.58 M Dilution adjustment 3.09 M3.1 M3.14 M2.89 M2.7 M 11.84 M Preferred dividends 3.09 M3.1 M3.14 M2.93 M2.7 M 11.88 M Diluted net income available to common stockholders 2.91 M2.18 M-491.39 K1.13 M1.71 M 4.54 M Basic earnings per share (Basic EPS) 0.080.06-0.010.030.05 0.13 Diluted earnings per share (Diluted EPS) 0.080.06-0.010.030.05 0.13 Average basic shares outstanding 28.75 M28.75 M28.75 M28.75 M28.75 M — Diluted shares outstanding 28.75 M28.75 M28.75 M28.75 M28.75 M — EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————— —